Infanrix hexa: new combined vaccine for infantsGlaxoSmithKline is introducing Infanrix hexa. MD’s empathy may affect patient outcomes LETTER: Another view on pharma rep detailing Putting the brakes on smoking Popular science Dr. Joe Schwarcz spreads his love of science through books for the public and by teaching doctors about what patients want to know New type of self-harming disorder observed in teens Abused girls embed objects in their skin to deal with trauma B.C. government and BCPhA announce drug-pricing agreement B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy. New pediatric indication for Reyataz Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age. Stelara approved for psoriasis Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis. Phase 1 of Alberta's new Pharmaceutical Strategy introduced Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8. First Previous 3963 3964 3965 3966 3967 Next Last
